Chief Executive Officer and Chairman-designate
Lamberto Andreotti was designated chief executive officer (CEO) of the company by the Board of Directors on March 2, 2010, and officially became CEO on May 4, 2010. Prior to becoming CEO, Lamberto was president and chief operating officer responsible for all of Bristol-Myers Squibb’s pharmaceutical operations worldwide. In March 2009, Lamberto was elected to the Board of Directors.
Lamberto joined Bristol-Myers Squibb in 1998 as vice president and general manager, Italy and European Oncology. In 2000, he was named president, Europe. In November 2002, Lamberto became senior vice president and president, International. Prior to joining Bristol-Myers Squibb, Lamberto held various senior roles at other pharmaceutical companies, including Farmitalia Carlo Erba, KABI Pharmacia and Pharmacia & Upjohn.
Lamberto earned his bachelor’s degree in engineering from the University of Rome. He obtained a master’s degree from the Massachusetts Institute of Technology.